LOEWE Biochemica GmbH was established in 1988 as a privately held company. Since almost 30 years the company is specialized in the development and production of premium diagnostic reagents for the detection of plant pathogens, covering methods from ELISA to molecular detection assays. Our main directive is to offer solutions for plant disease diagnosis by developing and producing high-quality serological and molecular products and providing fast and reliable service to our customers around the globe. Having implemented a quality management system according to ISO9001:2008, our staff is committed in maintaining and improving our already high quality standards, regarding the development and production of ELISA reagents, the LOEWE®FAST test series, our immuno fluorescence and molecular diagnostic reagents. Through collaboration with scientists in national and international projects, we are striving towards introducing new technologies and innovative tools into our portfolio, especially in the emerging field of molecular diagnostics.

Role and participation in the project

As SME partner, LOEWE®‘s role in the project is to exploit the results commercially, by bringing to the market validated tests. It will contribute by involvement in the creation of a policy board of important stakeholders and communication and dissemination of project results between actors (WP6, WP7). In addition it will work on market exploitation strategies through market analysis (WP4), training sessions and developing a quality label with other commercial partners for validated tests (WP7). Moreover the company will be involved in test performance studies for relevant pathogens (WP1).